RaffiJ, SureshR, BottoN, et al.The impact of dupilumab on patch testing and the prevalence of co-morbid allergic contact dermatitis in recalcitrant atopic dermatitis: A retrospective chart review. J Am Acad Dermatol. 2020; 82(1):132–138; doi: 10.1016/j.jaad.2019.09.028
2.
RussoF, SordiD, MadonnaS, et al.Paradoxical head and neck erythema in patients treated with dupilumab: Not only red face. Dermatitis. 2024; 35(4):421–423; doi: 10.1089/derm.2023.0381
3.
BaiH, MuraseEM, BottoNB, et al.Clear, patch, avoid, treat as a diagnostic and therapeutic strategy for management of recalcitrant adult eczematous dermatitis. Dermatitis. 2023; 34(4):343–346; doi: 10.1097/DER.0000000000000900
4.
MowadCM. Patch testing: Pitfalls and performance. Current Opinion in Allergy and Clinical Immunology., 2006; 6(5):340–344; doi: 10.1097/01.all.0000244794.03239.8e
5.
CoatesLC, FransenJ, HelliwellPS. Defining minimal disease activity in psoriatic arthritis: A proposed objective target for treatment. Ann Rheum Dis. 2010; 69(1):48–53; doi: 10.1136/ard.2008.102053
